Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis …

Y Gong, Y Yang - Life sciences, 2020 - Elsevier
Hepatic fibrosis (HF) is a wound-healing response that occurs during chronic liver injury and
features by an excessive accumulation of extracellular matrix (ECM) components. Activation …

Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis

X Liu, H Hu, JQ Yin - Liver International, 2006 - Wiley Online Library
Hepatic fibrosis is the common wound‐healing response to chronic liver injury. In this
process, activation of hepatic stellate cells is characteristic of cell proliferation and migration …

Liver fibrosis: therapeutic targets and advances in drug therapy

Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie… - Frontiers in cell and …, 2021 - frontiersin.org
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …

Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis

J Kim, W Kang, SH Kang, SH Park, JY Kim, S Yang… - Scientific reports, 2020 - nature.com
Hepatic fibrogenesis is characterized by activation of hepatic stellate cells (HSCs) and
accumulation of extracellular matrix (ECM). The impact of ECM on TGF-β-mediated …

Liver fibrogenesis: a new role for the renin–angiotensin system

R Bataller, P Sancho-Bru, P Ginês… - Antioxidants & redox …, 2005 - liebertpub.com
Liver fibrosis is the consequence of chronic liver injury of any etiology. When advanced,
fibrosis causes portal hypertension and liver insufficiency, and is a risk factor for developing …

Nrf2 protects stellate cells from Smad-dependent cell activation

V Prestigiacomo, L Suter-Dick - PloS one, 2018 - journals.plos.org
Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are
the primary effector of liver fibrosis. Several factors, including TGF-β1, PDGF and oxidative …

Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways

Q Cheng, C Li, C Yang, Y Zhong, D Wu, L Shi… - Chemico-biological …, 2019 - Elsevier
Liver fibrosis is a pathological wound-healing response caused by chronic liver damage due
to a virus, autoimmune disorder, or drugs. Hepatic stellate cells (HSCs) play an essential …

Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver

E Ramos-Tovar, P Muriel - Antioxidants, 2020 - mdpi.com
Activated hepatic stellate cells (HSCs) and myofibroblasts are the main producers of
extracellular matrix (ECM) proteins that form the fibrotic tissue that leads to hepatic fibrosis …

Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation

KL Yang, WT Chang, MY Hong, KC Hung… - PLoS One, 2017 - journals.plos.org
Current anti-fibrotic effect of antioxidants in vivo is disappointing due probably to the fact that
once liver fibrogenesis is established it is too advanced to be reversed by anti-oxidation …

Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities

Q Pei, Q Yi, L Tang - International Journal of Molecular Sciences, 2023 - mdpi.com
The liver is a critical system for metabolism in human beings, which plays an essential role
in an abundance of physiological processes and is vulnerable to endogenous or exogenous …